NCT01966640

Brief Summary

Child food allergy represent 6 to 8% of child in industrialised country. Within this allergy, peanuts and egg allergy are one of the most common. Actually when there is a suspicion of food allergy, the OPT is the gold standard for the diagnosis. During the OPT we give increasing doses of the allergen to the patient and evaluate threshold causing a clinical reaction. This test is associated with a risk of strong allergic reaction and need a medical supervision. Standard allergy test, like skin test or specific IgE test, can't be use for the diagnosis of these allergy. Some publications demonstrate that these tests lack sensibility and specificity for child food allergy diagnosis. New tests have to be develop to diagnosis child food allergy without risks. The BAT is a cellular test able to evaluate the basophiles activation by specific allergen in vitro. This test allow us to evaluate more physiologically the sensitization of patients to an allergen. It is already used in drug allergy and it has been evaluated in infant milk allergy in an other clinical trial. In this study we want to evaluate the sensitivity of BAT to the diagnosis of child food allergy compare to the gold standard test OPT. We will evaluate the BAT on 140 children with food allergy and compare this results with the OPT at the same time. If the BAT results can predict the sensitivity of children to food allergen, it could limit the use of the OPT and reduce the risk of this test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Sep 2013

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2013

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 21, 2013

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 11, 2019

Completed
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

5.3 years

First QC Date

October 11, 2013

Last Update Submit

April 13, 2026

Conditions

Keywords

diagnosis of allergyBasophil Activation Test

Outcome Measures

Primary Outcomes (1)

  • Sensitivity of the Basophil Activation Test

    Sensitivity of the BAT compare to OPT with a threshold value of 6% for the BAT in a population of child food allergy. Sensitivity is defined as the capacity for BAT to have a positive result when OAT result is also positive (diagnosis of allergy confirmed)

    Day 1

Secondary Outcomes (1)

  • Evaluation of the proportion of child positive to the BAT

    Day 1

Study Arms (1)

Child food allergy suspicion

EXPERIMENTAL

Basophil Activation Test realized in case of Child food egg and peanut allergy suspicion

Biological: Basophil Activation Test

Interventions

blood sample for Basophil Activation Test

Child food allergy suspicion

Eligibility Criteria

Age6 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Child older than 6 months and less than 18 years old
  • Diagnosis of type I allergy to peanut or egg
  • oral provocation test to peanut or egg programmed

You may not qualify if:

  • No possibility to assess blood sample

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UH Rouen

Rouen, 76031, France

Location

Related Publications (1)

  • Carrette M, Couderc L, Bubenheim M, Vidal A, Youssouf A, Boyer O, Marguet C, Martinet J. The combination of Ara h 2-sIgE and basophil activation test could be an alternative to oral food challenge in cases of suspected peanut allergy. Pediatr Allergy Immunol. 2023 Aug;34(8):e14007. doi: 10.1111/pai.14007.

MeSH Terms

Conditions

Peanut Hypersensitivity

Interventions

Basophil Degranulation Test

Condition Hierarchy (Ancestors)

Nut and Peanut HypersensitivityFood HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Immunologic TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesImmunologic Techniques

Study Officials

  • Laure COUDERC, Dr

    UH Rouen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2013

First Posted

October 21, 2013

Study Start

September 12, 2013

Primary Completion

January 11, 2019

Study Completion

January 11, 2019

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations